The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE).
Pharmacists can earn a maximum of 12.75 contact hours of CPE credit by attending one CPE session during each session block during AMCP Nexus 2018 (not including pre-conference programs and satellite symposia held in conjunction with the conference). To obtain credit, pharmacists, physicians, and nurses must attend a session in its entirety, participate in session-specific learning assessments, obtain a session-specific attendance code, complete a session evaluation, and record their participation online at http://amcplearn.org no later than 5:00 PM ET on Monday, November 26, 2018. No exceptions can be made after this date.
Target Audience and Conference Objectives
The education sessions at AMCP Nexus 2018 are designed to provide insights and solutions for managed care professionals (including pharmacists) who practice in managed care settings, and to help them maintain and enhance their knowledge, skills, and abilities.
Education sessions available during AMCP Nexus 2018 will deliver timely, practical information in five targeted program tracks:
- Preparing for the Next Generation of Care
- Drugs, Diseases and the Managed Care Impact
- Legislative and Regulatory Trends: From Rhetoric to Practice
- Managed Care Research in Action
- Specialty Management: Keeping Up with Runaway Innovation
By actively participating in the continuing education programming at AMCP Nexus 2018, managed care professionals should be able to:
- Summarize important trends with emerging payment models and contracting, and the impact on managed care pharmacy.
- Describe the most recent evidence-based approaches to specific diseases and the impact on managed care pharmacy.
- Discuss the latest legislative and regulatory issues in the health care environment and their impact on managed care pharmacy.
- Restate findings from cutting-edge managed care research.
- Characterize the rapidly changing specialty pharmaceutical landscape and identify efficient and effective ways to manage this growing market segment.
- Summarize the latest issues impacting managed care pharmacy.
The CPE Monitor system became mandatory for all pharmacists, technicians, and CPE providers on January 1, 2013. If you have not obtained your National Association of Boards of Pharmacy (NABP) e-profile ID, please visit www.nabp.net/programs/cpe-monitor/cpe-monitor-service. If you have any questions about this system or your number, please contact NABP customer support at 847-391-4406, Monday–Friday between 9:00 AM and 5:00 PM CT.
Information about the amount of CPE credit pharmacists earn at AMCP Nexus 2018 is transmitted electronically by AMCP to NABP. Pharmacists who log in to CPE Monitor will be able to access information about CPE credit earned at AMCP Nexus 2018 approximately 72 hours after successful submission.
Some states have special requirements for program content to meet state requirements for continuing education. Please check with your state Board of Pharmacy to determine if such requirements exist and to determine if the CPE sessions at AMCP Nexus 2018 meet those requirements.
Continuing Pharmacy Education Session Types
All continuing education sessions at AMCP Nexus 2018 are knowledge-based (designed primarily for pharmacists to acquire factual knowledge).
Education Session Handouts
Handouts for education sessions will be posted online prior to the start of the conference. Please be aware that handouts will not be distributed in session rooms.
AMCP strives to produce quality educational programming that is free of bias and commercialism. We encourage attendees to convey to AMCP information regarding programming that appears to contain bias or overt commercialism. It is AMCP’s policy to address any issues relating to educational programming content or quality immediately. Should any registrant be dissatisfied with the quality of the continuing education programming offered at an AMCP meeting, a request in writing must be submitted to AMCP within 5 days of the conclusion of the program for consideration of a refund of registration fees.
ACPE has adopted (and requires all accredited CPE providers to abide by) the ACCME Standards for Commercial Support. These standards require that all CPE activities are planned independent of commercial interest and content is delivered with full disclosure and equitable balance.
As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards of Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
All instructional materials for continuing education sessions at AMCP Nexus 2018 undergo an intensive review process to ensure compliance with the Standards for Commercial Support. Disclosures of relevant financial relationships for all parties involved in the planning or delivery of continuing education sessions will appear in the Final Program or be included in slides and announcements at the beginning of each session. AMCP has a mechanism in place for ensuring that any actual conflicts of interest are resolved prior to any continuing education session taking place.
Disclosure of Unlabeled Use
Educational activities may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. AMCP does not recommend the use of any agent outside of the labeled indications. The opinions expressed in educational activities are those of the faculty and do not necessarily represent the views of AMCP. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in these activities are not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
American with Disabilities Act
AMCP fully intends to comply with the legal requirements of the American with Disabilities Act. If any participant of this conference is in need of accommodation, please do not hesitate to contact AMCP at (703) 684-2600 or visit AMCP registration onsite at the conference.